May 19, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was cited as a source for an article published by NPR on whether people who have gotten vaccinated for COVID-19 should have their antibodies tested.
May 21, 2021
Message
May 25, 2021
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases was interviewed by two local TV stations for a story they did on myocarditis and COVID-19 vaccines. An advisory committee to the CDC is looking into reports that some teenagers and young adults who have received the COVID-19 vaccine have experienced heart inflammation. They’re reviewing these cases to see if there’s a possible connection.
November 30, 2021
A new study by UC researcher Nancy Jennings shows how media use for "tweens" changed during COVID-19 lockdowns
November 29, 2021
Over the Thanksgiving weekend, the World Health Organization gave the name omicron to the newest identified version of SARS-CoV-2 and called it a variant of concern. There is still much to be learned about this latest variant and how potentially dangerous it is. In a story on the variant, Cincinnati.com interview Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
November 18, 2021
Should pediatricians give COVID-19 vaccines "off label" as they can with other drugs
November 18, 2021
Medical misinformation, such as taking detox baths to remove the COVID-19 vaccine from the body, are rampant on social media.
November 18, 2021
COVID-19 cases in the region are rising just ahead of the Thanksgiving holiday. Health experts are concerned about people getting together for the holidays, especially for certain groups. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was one of the experts interviewed for a story produced by WLWT-TV.
November 17, 2021
University of Cincinnati's Dr. Robert Van Haren was featured in a Scientific American article discussing how the pause in lung cancer screening affected patients during the COVID-19 pandemic.
November 15, 2021
Local 12 featured University of Cincinnati researchers studying how art therapy and robotic pets can affect the mood of patients with long-haul COVID-19.
November 10, 2021
With people wearing masks over the past 18 months or so to ward off COVID-19, the incidence of the common cold has been reduced during that time. However, as more people get vaccines and boosters, and mask mandates are eased in some instances, the common cold could be poised to make a comeback as we head into the fall and winter months. Giddy posted a primer on what causes the common cold and how to combat it and one of the expert sources they cited was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
November 3, 2021
UC is part of a multi-institutional grant of nearly $2 million from the Centers for Disease Control and Prevention to improve the design, function and safety of personal protective equipment. UC researchers will work with teams from Iowa State University and the University of California-Davis on this four-year grant. One of the goals is to develop self-decontaminating PPE featuring high-protection efficiency
October 29, 2021
The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.
October 28, 2021
The UPI posted a story about research led by Katie Phillips, MD, assistant professor in the Department of Otolaryngology, Head & Neck Surgery at the UC College of Medicine on coping mechanisms for people who have had a diminished or lost sense of smell from COVID-19. Two of the common adaptations among patients she saw at her clinic were incorporating texture and temperature into their food and drink.
October 22, 2021
The University of Cincinnati's Dr. Bryan Hambley was featured in a Cincinnati Enquirer article highlighting how Colin Powell's death has highlighted the importance of vaccinations for multiple myeloma patients who are immunocompromised.
October 21, 2021
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from UC found some common coping mechanisms that helped COVID patients deal with a lessened sense of smell, which severely impacts the sense of taste. The study was published in the International Forum of Allergies and Rhinology. The combination of the loss of smell and taste, which are also known as the chemosensory senses, due to COVID-19 has been particularly devastating, with research showing associated depression, anxiety and impaired quality of life. It is something Katie Phillips, MD, assistant professor in the Department of Otolaryngology, Head & Neck Surgery at the UC College of Medicine sees in many COVID patients who come into her clinic.
October 14, 2021
Carl Fichtenbaum, MD, of the UC Division of Infectious Diseases in the College of Medicine was interviewed by WKRC-TV, Local 12 for a story on how dropping COVID-19 cases across the country could signal herd immunity.
October 11, 2021
Angenette Levy of 55KRC featured Dr. Erica Birkley on the Simply Medicine podcast to discuss ways to manage mask-related anxiety.